ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Xu et al. [13] reported that decreased expression of adiponectin might be partially responsible for alcohol-induced liver injury in mice, and that adiponectin treatment significantly attenuated inflammation of both alcoholic and nonalcoholic fatty liver diseases in mice as was indicated by the suppression of TNF-alpha level.